Literature DB >> 7601953

The Muir-Torre syndrome: a 25-year retrospect.

R A Schwartz1, D P Torre.   

Abstract

The Torre or Muir-Torre syndrome consists of certain types of sebaceous neoplasms of the skin, with or without keratoacanthomas, and one or more low-grade visceral malignancies in the absence of other predisposing factors. The sebaceous tumors are relatively uncommon or rare: sebaceous adenoma, sebaceous epithelioma, basal cell epithelioma with sebaceous differentiation, and sebaceous carcinoma. Sebaceous hyperplasia and hamartomas such as nevus sebaceus of Jadassohn, with or without a sebaceous epithelioma within it, are not a defining part of this syndrome. Sebaceous hyperplasia is common in elderly light-complexioned people with or without this syndrome. Nevus sebaceus of Jadassohn is not rare and is predisposed to the development of other neoplasms within it, including occasionally a sebaceous epithelioma. Colonic polyps are frequently present. Muir-Torre syndrome requires recognition because affected patients are at risk of multiple primary malignancies. The skin lesions may be the first sign of this syndrome, although more often its cutaneous signs follow the diagnosis of at least the first visceral malignancy. The Muir-Torre syndrome portends the greater possibility of a favorable prognosis than might be anticipated otherwise because the visceral cancers are usually low-grade malignancies. However, they are often multiple, so identifying such patients will affect their management in a few ways. Because these indolent visceral malignancies tend to permit prolonged survival, even metastatic disease may respond well to aggressive surgical treatment. The sebaceous cancers in this syndrome, like the visceral malignancies, are less aggressive than their counterparts unassociated with this syndrome. Because this syndrome is inherited in an autosomal dominant manner, identifying one patient means delineating an entire family, which should be investigated. This syndrome may be caused by a defective mismatch DNA repair gene.

Entities:  

Mesh:

Year:  1995        PMID: 7601953     DOI: 10.1016/0190-9622(95)90017-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  52 in total

1.  Microsatellite instability testing in Korean patients with colorectal cancer.

Authors:  Jung Ryul Oh; Duck-Woo Kim; Hye Seung Lee; Hee Eun Lee; Sung Min Lee; Je-Ho Jang; Sung-Bum Kang; Ja-Lok Ku; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  Preoperative assessment of the eye and periocular region.

Authors:  John R Burroughs; Richard L Anderson; James R Patrinely; David A Weinberg; John D McCann; Tristan F W McMullan
Journal:  Semin Plast Surg       Date:  2007-02       Impact factor: 2.314

3.  Muir-torre syndrome: a case report.

Authors:  Heather J Higgins; Melissa Voutsalath; Jean M Holland
Journal:  J Clin Aesthet Dermatol       Date:  2009-08

4.  The role of immunohistochemistry in the Muir-Torre Syndrome.

Authors:  Cláudia Marina Puga Barbosa Oliveira; Jullyene Gomes de Campos; Maiko Ramacos Maia; Larissa Eva dos Santos Lobo; Fábio Francesconi do Valle
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

5.  Muir-Torre Syndrome: expanding the genotype and phenotype--a further family with a MSH6 mutation.

Authors:  H R Murphy; R Armstrong; D Cairns; K L Greenhalgh
Journal:  Fam Cancer       Date:  2008-01-31       Impact factor: 2.375

Review 6.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

Review 7.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

Review 8.  [Hereditary colon cancer in Lynch syndrome/HNPCC syndrome in Germany].

Authors:  R Büttner; N Friedrichs
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

9.  First case report of Muir-Torre syndrome associated with non-small cell lung cancer.

Authors:  L Nolan; D Eccles; E Cross; G Crawford; N Beck; A Bateman; C Ottensmeier
Journal:  Fam Cancer       Date:  2009-05-16       Impact factor: 2.375

Review 10.  Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.

Authors:  Iyer Vishwas Neelakantan; Silvana Di Palma; C E T Smith; A McCoombe
Journal:  Head Neck Pathol       Date:  2015-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.